Praziquantel EP Impurity B

Praziquantel EP Impurity B is a structurally related degradation byproduct arising from oxidative modification of the parent bicyclic core of praziquantel. It retains the pyrazine-piperazine scaffold but features a hydroxylated aromatic ring substitution pattern distinct from the native 2,3,10-trioxapraziquantel framework. The compound exhibits a piperazine-linked phenolic hydroxyl group and a substituted pyrazine ring, conferring altered H-bonding and chromatographic properties. This impurity serves as a critical HPLC reference standard for quantifying oxidative degradation pathways in praziquantel formulations under ICH Q1A(R2) stability protocols.